TLR-2 and borrellia (lyme)

D

duncan

Senior Member
Messages
2,240
I would interpret it the same way. I notice the publication date is 2005. It is also primarily a German endeavor, and that country hasn't been as quick as others to wholeheartedly adhere to IDSA Guidelines.

I wonder if there were ever any follow-up studies.

Incidentally, you would think the NIH would be following this lead, or even something similar, considering its principal, if not sole, focus these days is diagnostics.
 
Last edited:
D

duncan

Senior Member
Messages
2,240
rsID? Boy, do I feel ignorant... This is gene talk? I can almost guarantee the NIH isn't looking at this relative to Lyme patients. :)
 
V

Valentijn

Senior Member
Messages
15,786
duncan said:
I can almost guarantee the NIH isn't looking at this relative to Lyme patients. :)
Click to expand...
It's been researched a fair bit regarding other infections, and it sounds like variations elsewhere in the gene often have a very significant impact.

23andMe data for the rest of the gene looks very normal for 31 patients I have full data for, when compared to 31 controls. One possible exception is rs3804100 where we have 2 patients and 0 controls who are homozygous for the rare version. The usual homozygous prevalence is 1.2%, but we're at 6.5%. It could just be a fluke though, since it's pretty small sample size.
 
D

duncan

Senior Member
Messages
2,240
"23andMe data for the rest...looks very normal for 31 patients..." Lyme patients?
 
You must log in or register to reply here.
Back